THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 164 filers reported holding THERAPEUTICSMD INC in Q1 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $62,000 | -37.4% | 83,305 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $99,000 | -11.6% | 83,305 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $112,000 | +10.9% | 83,305 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $101,000 | -23.5% | 83,305 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $132,000 | +26.9% | 83,305 | 0.0% | 0.00% | +50.0% |
Q2 2020 | $104,000 | +18.2% | 83,305 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $88,000 | -56.4% | 83,305 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $202,000 | -33.1% | 83,305 | 0.0% | 0.00% | -40.0% |
Q3 2019 | $302,000 | +39.2% | 83,305 | 0.0% | 0.01% | +66.7% |
Q2 2019 | $217,000 | -46.6% | 83,305 | 0.0% | 0.00% | -40.0% |
Q1 2019 | $406,000 | +28.1% | 83,305 | 0.0% | 0.01% | +25.0% |
Q4 2018 | $317,000 | -41.9% | 83,305 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $546,000 | +27.0% | 83,305 | +21.0% | 0.01% | +25.0% |
Q2 2018 | $430,000 | +54.1% | 68,841 | +20.3% | 0.00% | +33.3% |
Q1 2018 | $279,000 | – | 57,212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |